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Background
There is growing evidence that common diseases might
n o tr e s u l tf r o maf e wc o m m o nv a r i a n t s ,b u tr a t h e rf r o m
many rare variants across many genes/loci. This is likely
to be particularly true for disorders such as autism where
the fecundity of affected individuals is exceptionally low
(~5%) and thus disease-predisposing alleles are unlikely
to be transmitted. Since these different disease-contribut-
ing genes give rise to a shared disease phenotype, it is
likely that their protein products contribute to shared
biological processes, such as particular protein pathways
or cellular networks. Identifying the common network(s)
among these genes would allow the screening of a small
subset of genes for early diagnosis and these networks
could present multiple points for early intervention.
Methods
We examined two independent sets of de novo copy num-
ber variants (CNVs) identified in individuals with autism
spectrum disorders (ASDs): (i) a large discovery set of 73
CNVs identified in 54 patients (median size 118Kb) from
the Autism Genome Project (AGP) consortium [1]; and (ii)
a small validation/replication set of 28 CNVs identified in
24 patients (median size 3Mb) [2]. To identify unexpected
shared features among genes overlapped by these CNVs,
we exploited phenotype data arising from the disruption of
~6000 human orthologues in mouse. We infer that genes
are likely to act in the same biological process if, when dis-
rupted in mouse, they exhibit comparable phenotypes.
Thus, we aim to identify significantly over-represented
mouse phenotypes among sets of human genes of interest
(e.g. genes overlapped by autism-associated CNVs) [3].
Results
Among genes overlapped by the AGP CNVs, significant
enrichments of specific mouse phenotypes were discovered
(FDR<5%), most of which were either replicated (FDR<5%)
or validated (p<0.05) in the Marshall set, including: (i) A
significant enrichment of genes associated with four abnor-
mal synaptic transmission phenotypes; (ii) A significant
enrichment of genes associated with >10 behavioural phe-
notypes and five hearing phenotypes that are only found
within duplicated CNVs. Many of these duplication-specific
phenotypic associations are readily comparable to ASD
symptoms, such as abnormal motor learning (60-80% of
individuals with ASD exhibit impaired coordination), non-
convulsive seizures (~1/3 of individuals with ASD suffer sei-
zures, commonly non-convulsive) and sensorineural hearing
impairment (25-40% individuals with ASD have hearing
impairments). These enrichments identify >100 largely
novel candidate genes and provide causal hypothesis for
between 19-83% of patients in each cohort.
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